ABNewswire

10/09/2026

Islamic Finance Market to Hit USD 8.46 Trillion by 2031, as Banking, Sukuk and Takaful Gain Attention, Says Mordor Intelligence

Islamic Finance Market to Hit USD 8.46 Trillion by 2031, as Banking, Sukuk and Takaful Gain Attention, Says Mordor Intelligence Posted on October 9, 2026 by admin Islamic Finance Market Size and Share | Mordor Intelligence Mordor Intelligence has published a new report on the Islamic finance market,...

10/09/2026

Immersion Cooling Fluids Market to Reach USD 4.49 Billion by 2031 as Hyperscale Data Centers Record 11.12% CAGR | Says Mordor Intelligence

Immersion Cooling Fluids Market to Reach USD 4.49 Billion by 2031 as Hyperscale Data Centers Record 11.12% CAGR | Says Mordor Intelligence Posted on October 9, 2026 by admin Immersion Cooling Fluids Market The latest research by Mordor Intelligence covers the “Immersion Cooling Fluids” deliverin...

10/09/2026

Cutaneous Lupus Erythematosus Market to Reach USD 4.3 Billion by 2036, Driven by Targeted Immunotherapies and Rising Demand for Effective Treatments | DelveInsight

Cutaneous Lupus Erythematosus Market to Reach USD 4.3 Billion by 2036, Driven by Targeted Immunotherapies and Rising Demand for Effective Treatments | DelveInsight Posted on October 9, 2026 by admin The market dynamics for Cutaneous Lupus Erythematosus (CLE) are witnessing significant growth, driven...

10/09/2026

Epstein-Barr Virus (EBV) Market is Projected to Witness Significant Growth by 2036 Owing to Advancements in Targeted Immunotherapies and Vaccine Development | DelveInsight

Epstein-Barr Virus (EBV) Market is Projected to Witness Significant Growth by 2036 Owing to Advancements in Targeted Immunotherapies and Vaccine Development | DelveInsight Posted on October 9, 2026 by admin The market dynamics for Epstein-Barr virus (EBV) are evolving, driven by the high prevalence....

10/09/2026

Osteoarthritis Market is Projected to Reach USD 47 Billion by 2036 Owing to Advancements in Novel Therapies | DelveInsight

Osteoarthritis Market is Projected to Reach USD 47 Billion by 2036 Owing to Advancements in Novel Therapies | DelveInsight Posted on October 9, 2026 by admin The market dynamics for osteoarthritis are witnessing steady growth, driven by the rising disease burden associated with aging populations, in...

10/09/2026

Bulimia Nervosa Market to Witness Steady Growth Through 2036 Amid Rising Diagnoses and Limited Pharmacological Advancements

Bulimia Nervosa Market to Witness Steady Growth Through 2036 Amid Rising Diagnoses and Limited Pharmacological Advancements Posted on October 9, 2026 by admin (Albany, New York) – October 09, 2026: DelveInsight’s “Bulimia Nervosa Market Insights, Epidemiology, and Market Forecast – 2036” ...

10/09/2026

Bone Metastasis in Solid Tumors Market: Steady Growth Driven by Rising Cancer Incidence and Evolving Targeted Therapies Through 2036

Bone Metastasis in Solid Tumors Market: Steady Growth Driven by Rising Cancer Incidence and Evolving Targeted Therapies Through 2036 Posted on October 9, 2026 by admin (Albany, New York) – October 09, 2026: DelveInsight’s “Bone Metastasis in Solid Tumor Market Insights, Epidemiology, and Mark...

10/09/2026

IgA Nephropathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences

10/09/2026

Mantle Cell Lymphoma Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | PharmaEngine, Jiangsu Hansoh Pharma, Galapagos NV, Miltenyi Biomedicine

Mantle Cell Lymphoma Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | PharmaEngine, Jiangsu Hansoh Pharma, Galapagos NV, Miltenyi Biomedicine Posted on October 9, 2026 by admin (Albany, New York) – October 09, 2026: As per DelveInsight’s as...

10/09/2026

HER2-Positive Breast Cancer Pipeline 2026: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx

HER2-Positive Breast Cancer Pipeline 2026: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx Posted on October 9, 2026 by admin (Albany, New York) – October 09, 2026: As per DelveInsight’s as...